VSE Corporation (NASDAQ:VSEC) Analysts Just Slashed This Year's Estimates

The analysts covering VSE Corporation (NASDAQ:VSEC) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon.

Following the downgrade, the latest consensus from VSE's six analysts is for revenues of US$1.2b in 2025, which would reflect a meaningful 11% improvement in sales compared to the last 12 months. Statutory earnings per share are presumed to jump 104% to US$3.61. Before this latest update, the analysts had been forecasting revenues of US$1.4b and earnings per share (EPS) of US$4.04 in 2025. It looks like analyst sentiment has declined substantially, with a measurable cut to revenue estimates and a real cut to earnings per share numbers as well.

Check out our latest analysis for VSE

earnings-and-revenue-growth
NasdaqGS:VSEC Earnings and Revenue Growth March 9th 2025

Despite the cuts to forecast earnings, there was no real change to the US$140 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the VSE's past performance and to peers in the same industry. The analysts are definitely expecting VSE's growth to accelerate, with the forecast 11% annualised growth to the end of 2025 ranking favourably alongside historical growth of 7.8% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.7% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that VSE is expected to grow much faster than its industry.

Advertisement

The Bottom Line

The most important thing to take away is that analysts cut their earnings per share estimates, expecting a clear decline in business conditions. Unfortunately, analysts also downgraded their revenue estimates, although our data indicates revenues are expected to perform better than the wider market. We're also surprised to see that the price target went unchanged. Still, deteriorating business conditions (assuming accurate forecasts!) can be a leading indicator for the stock price, so we wouldn't blame investors for being more cautious on VSE after the downgrade.

So things certainly aren't looking great, and you should also know that we've spotted some potential warning signs with VSE, including its declining profit margins. Learn more, and discover the 2 other warning signs we've identified, for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:VSEC

VSE

Engages in providing aviation aftermarket parts distribution and maintenance, repair, and overhaul services for air transportation assets for commercial and government markets.

High growth potential with solid track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0775.1% undervalued
114 users have followed this narrative
1 users have commented on this narrative
20 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9823.0% undervalued
36 users have followed this narrative
0 users have commented on this narrative
30 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1559.0% undervalued
15 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3653.2% undervalued
12 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

CO
composite32
FRU logo
composite32 on Freehold Royalties ·

Freehold: Offers a fantastic growth-income intersection up to $50 WTI. Below $50 WTI, it may offer historic opportunities in terms of ROI.

Fair Value:CA$19.813.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
ADBE logo
Vestra on Adobe ·

Adobe (ADBE): Record Q1 AI-Revenue and the End of the Shantanu Narayen Era

Fair Value:US$572.452.9% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
MDXH logo
Vestra on MDxHealth ·

MDxHealth (MDXH): Liquid Biopsy Hypergrowth and the Strategic Path to 10% EBITDA Margins

Fair Value:US$7.556.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.378.3% undervalued
53 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.6% undervalued
1306 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9823.0% undervalued
36 users have followed this narrative
0 users have commented on this narrative
30 users have liked this narrative